SCHEMBL16514634

SCHEMBL16514634

CN1CCN(c2ccc(Nc3ncc4cccc(-c5cc(C=CC(N)=O)ccc5F)c4n3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.53
JAK2 O60674 4/20 0.53
FGFR1 P11362 1/20 0.51
KDR P35968 1/20 0.51
EGFR P00533 2/20 0.49
CDK4 P11802 3/20 0.49
CCND1 P24385 2/20 0.49
FGFR4 P22455 2/20 0.48
FGFR2 P21802 1/20 0.47
PTK2 Q05397 2/20 0.47
FLT3 P36888 1/20 0.46
BTK Q06187 1/20 0.46
CCND2 P30279 1/20 0.46
CCND3 P30281 1/20 0.46
JAK1 P23458 1/20 0.45
BRD2 P25440 1/20 0.45
JAK3 P52333 1/20 0.45
BRD3 Q15059 1/20 0.45
BRDT Q58F21 1/20 0.45
AURKA O14965 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16513550 0.91 BRD4 (0.53) BRD4JAK2FGFR1KDREGFR
SCHEMBL16513811 0.83 BRD4 (0.60) BRD4JAK2FGFR1KDREGFR
SCHEMBL29847690 0.83 FGFR1 (0.71) JAK2FGFR1KDREGFRFGFR2
SCHEMBL16513623 0.83 FGFR1 (0.71) JAK2FGFR1KDREGFRFGFR2
SCHEMBL16514436 0.81 EGFR (0.62) BRD4JAK2FGFR1KDREGFR
SCHEMBL16514597 0.80 TTK (0.56) BRD4JAK2FGFR1KDREGFR
SCHEMBL19096959 0.79 MAPK10 (0.55) BRD4JAK2EGFRCDK4CCND1
SCHEMBL16513467 0.79 EGFR (0.58) BRD4JAK2FGFR1KDREGFR
SCHEMBL16514973 0.79 EGFR (0.52) BRD4JAK2FGFR1KDREGFR
SCHEMBL16514168 0.78 FGFR2 (0.52) BRD4JAK2FGFR1KDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035936-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NeuPharma, Inc. (US) 2016-06-29 EP disclosed
WO-2015027222-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2015-02-26 WO disclosed